Biosafety testing for GMP master cell banks(MCBS) and retroviral vectors for NCI clinical trials

Ended Indefinite Delivery Contract Awarded Last action

Contract number
HHSN261201300026I
Awardee
Awarding agency
Task orders
17 $1,253,389 obligated

Award facts

Opportunity
Combined order value
$1,253,389 Current and potential, with all options
Last date to order 100% complete
IDV ceiling 20% used
$6,138,096.07
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

Task orders

Task order Ordering agency Obligated Awarded
Task order for biosafety testing of GMP master cell banks HHSN26100007 National Cancer Institute (NIH) $127,773
Biosafety testing of a 293GP master cell bank used for production of patient-specifica gammaretroviral ventors encoding… HHSN26100019 National Cancer Institute (NIH) $127,773
Biosafety testing of a 293T master cell bank used for production of patient specific lentiviral vectors encoding HHSN26100018 National Cancer Institute (NIH) $127,773
Biosafety testing of a kras TCR clinical product HHSN26100016 National Cancer Institute (NIH) $127,773
Biosafety testing of a kras TCR clinical product HHSN26100017 National Cancer Institute (NIH) $55,987
Bioreliance corp:1108045 [14-066534] HHSN26100014 National Cancer Institute (NIH) $39,085
Bioreliance corp:1108045 [15-013450] HHSN26100015 National Cancer Institute (NIH) $39,085
Package two sterility testing on one clinical reagent in support of an upcoming clinical trial. HHSN26100006 National Cancer Institute (NIH) $39,085
Order to fund the minimum for option period 1 for master cell bank testing HHSN26100005 National Cancer Institute (NIH) $94,587
L bioreliance corp:1108045 [14-042863] HHSN26100013 National Cancer Institute (NIH) $91,832
Line item 1: sterility (510120GMP.BSV) units: each catalog#: 510120GMP.BSV HHSN26100004 National Cancer Institute (NIH) $37,947
Line item 1: sterility (510120GMP.BSV) units: each catalog#: 510120GMP.BSV HHSN26100003 National Cancer Institute (NIH) $37,947
Line item 1: sterility (510120GMP.BSV) units: each catalog#: 510120GMP.BSV HHSN26100012 National Cancer Institute (NIH) $91,832
Line item 3: cell culture identification (380801.BSV) units: each catalog#: 380801.BSV HHSN26100011 National Cancer Institute (NIH) $89,114
Biosafety testing HHSN26100010 National Cancer Institute (NIH) $37,947
Line item 1: sterility (510120GMP.BSV) units: each catalog#: 510120GMP. Pots#14-003562 HHSN26100002 National Cancer Institute (NIH) $87,850
Biosafety testing of GMP mcbs and retroviral vectors for NCI clinical trials HHSN26100001 National Cancer Institute (NIH) $0
Show all 17

Transactions

Action Obligated Date
Exercise an Option 6 $0
Other Administrative Action 5 $0
Exercise an Option 4 $0
Change Order 3 $0
Exercise an Option 2 $0
Change Order 1 $0
Original award $0

Quick answers

Who was awarded contract HHSN261201300026I?

HHSN261201300026I was awarded to Bioreliance Corporation by National Cancer Institute (National Institutes of Health) on June 25, 2013.

How much is contract HHSN261201300026I worth?

Orders under HHSN261201300026I have obligated $1,253,389. HHSN261201300026I's own ceiling is $6,138,096.

How many orders have been placed under contract HHSN261201300026I?

17 orders have been placed under HHSN261201300026I, the latest on June 14, 2016.

Who can order from contract HHSN261201300026I?

HHSN261201300026I is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract HHSN261201300026I competed?

The extent of competition for HHSN261201300026I was competed under sap. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV
Try for free Login